Hansen Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 11.2572 million yuan, a year-on-year decrease of 80.68%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Hansen Pharmaceutical released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 269 million yuan, a year-on-year increase of 6.00%. The net profit attributable to shareholders of the listed company was 11.2572 million yuan, a year-on-year decrease of 80.68%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 9.1164 million yuan, a year-on-year decrease of 83.49%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments